North European Oil Royalty Trust (NRT) is expected to report for 1Q. Oncolytics Biotech Inc (ONC.T,ONCY) is expected to report $-0.09 for 4Q. Opus Genetics Inc (IRD) is expected to report $-0.15 for ...
ANAB remains risky despite new clinical data and partnerships; past successes haven't been replicated, and management's transparency issues raise concerns. The recent deal for Imsidolimab reflects ...
Erratum: Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma Anti–vascular endothelial growth factor therapy enhances PD-1 ...
Texas Senate Bill 3 is backed by Lt. Gov. Dan Patrick and seeks to tighten regulations around THC products sold in convenience stores and vape shops. Patrick first launched the bill in December ...
Those new beginnings include the debut of With Love, Meghan, which premiered on March 4, and the first products from her renamed As ever venture. In partnership with Netflix, As ever will sell a ...
Discovering AnaptysBio: A Closer Look AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in ...
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company ...
Finding Canadian alternatives to American products can be challenging, which is why we've put together this handy guide on Canadian fashion and beauty brands. If you're an avid fashion and beauty ...
AnaptysBio, Inc, a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results